Skip to main content
. 2016 Jun 23;7(36):57737–57751. doi: 10.18632/oncotarget.10252

Figure 6. Changes in signaling pathways in different HER2-positive cancer cell lines.

Figure 6

The MAPK and Akt pathways and their phosphorylation patterns, as assessed by Western blotting, following trastuzumab treatment for 1 h. The data are presented as the mean of three independent experiments.